Unknown PHASE2 INTERVENTIONAL 2-arm NCT03725254

CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC

Curative Chemoradiotherapy Versus Radical Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of Colorectal Cancer

Sponsor: Fudan University

Conditions Colorectal Cancer Para-aortic Lymph Node Metastasis Retroperitoneal Lymph Node Metastasis

Interventions chemoradiotherapy lymphadenectomy

Updated 6 times since 2018 Last updated: Jan 19, 2019 Started: Oct 20, 2018 Primary completion: Oct 1, 2021 Completion: Oct 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Colorectal Cancer and Para-aortic Lymph Node Metastasis, this trial is ongoing. The trial is conducted by Fudan University and has accumulated 6 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Nov 2024 — Present [monthly]

Unknown PHASE2

Status: Recruiting → Unknown
Sep 2024 — Nov 2024 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jan 2021 — Jul 2024 [monthly]

Recruiting PHASE2
Feb 2019 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Nov 2018 — Feb 2019 [monthly]

Not Yet Recruiting PHASE2

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fudan University

Data source: Fudan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China